SCOTTSDALE, Ariz., May 1, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most ...
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...
- Synuclein-One Study plenary session on Monday, April 15 at 9:15 a.m. MT will report the detection of cutaneous phosphorylated alpha-synuclein in patients with dementia with Lewy bodies and mild ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback